Battery Management Corp. holds a concentrated book of 5 stocks worth $425.8M as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). Their largest long position is SERVICETITAN INC at 49% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1548594/holdings"
Use Arkolith to show Battery Management Corp.'s latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
0% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
No trims or exits this quarter.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Servicetitan Inc SHS CL A | $209.4M | 3.30M | 49.2% | —Held | |
| 2 | Braze Inc COM CL A | $109.3M | 4.63M | 25.7% | ▲+42% Added · +1.4M sh | |
| 3 | Kodiak AI Inc. COM | $78.8M | 11.36M | 18.5% | —Held | |
| 4 | Sprinklr Inc CL A | $14.4M | 2.40M | 3.4% | —Held | |
| 5 | Champions Oncology Inc COM NEW | $13.9M | 2.42M | 3.3% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 5 | $425.8M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 5 | $622.8M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 5 | $524.8M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 6 | $569.2M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 7 | $687.4M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 6, 2025 | 7 | $781.4M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 | 5 | $325.0M | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 | 5 | $380.9M | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 | 5 | $453.5M | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 5 | $559.1M | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 5 | $381.6M | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 7 | $484.7M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 8 | $693.6M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Apr 4, 2023 | 8 | $12.4B | 13F-HR/A |
| Q3 2022 | Sep 30, 2022 | Apr 4, 2023 | 8 | $8.5B | 13F-HR/A |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 8 | $603.3M | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 | 9 | $656.8M | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 9 | $740.6M | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 | 11 | $2.1B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 16, 2021 | 10 | $1.8B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 17, 2021 | 8 | $785.1M | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 12, 2021 | 6 | $395.2M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.